Miscarried ‘cervical cancer vaccination,’ starting re-tender this week
While the Public Procurement Service’s tender for Gardasil and Cervarix, the subject of the National Immunization Program for cervical cancer vaccination, was finally miscarried, the Korea Centers for Diseases Control and Prevention(KCDC) announced a plan to get on a re-tender within this week.
...Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
